Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

NCT02583919 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: ISIS-GCGRRx- Dose Level 1
DRUG: ISIS-GCGRRx- Dose Level 2
DRUG: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.